probucol has been researched along with Anemia, Hemolytic in 1 studies
Probucol: A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993).
probucol : A dithioketal that is propane-2,2-dithiol in which the hydrogens attached to both sulfur atoms are replaced by 3,5-di-tert-butyl-4-hydroxyphenyl groups. An anticholesteremic drug with antioxidant and anti-inflammatory properties, it is used to treat high levels of cholesterol in blood.
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, TM | 1 |
| Mao, SJ | 1 |
| Lai, ST | 1 |
| Chang, CC | 1 |
| Yang, MC | 1 |
| Chen, NC | 1 |
| Chou, SC | 1 |
| Pan, JP | 1 |
1 other study available for probucol and Anemia, Hemolytic
| Article | Year |
|---|---|
Haemoglobin-induced oxidative stress is associated with both endogenous peroxidase activity and H2O2 generation from polyunsaturated fatty acids.
Topics: Anemia, Hemolytic; Antioxidants; Catalase; Endothelial Cells; Fatty Acids, Unsaturated; Hemoglobins; | 2011 |